View Older Stories View More Recent Stories

Jun 11, 2014 11:27AM Roth Comments on Regeneron's (REGN) MAA Submission for EYLEA to EU; Reaffirms 'Buy' Rating
Jun 11, 2014 07:56AM Roth Positive on TG Therapeutics (TGTX) into EHA Presentation
Jun 10, 2014 10:41AM Roth Affirms 'Buy' Rating on MEI Pharma (MEIP); New AML Treatment Data Bolsters Confidence
Jun 10, 2014 09:38AM Roth Halves PT on Dendreon (DNDN) to 50c; Things Aren't Shaping Up Nicely
Jun 9, 2014 10:20AM Roth Keeps Pharmacyclics (PCYC) at 'Buy'; Imbruvica sNDA Selected for Priority Review by FDA
Jun 9, 2014 07:28AM Roth Capital Starts MacroGenics (MGNX) at Buy
Jun 5, 2014 07:42PM Marrone Bio Innovations Announces Pricing of Follow-on Offering
Jun 5, 2014 04:08PM Hudson Technologies, Inc. (HDSN) Plans Common Stock Offering
Jun 4, 2014 04:23PM Culture Still Intact at Curis (CRIS) Following Management Shift; Roth Affirms at 'Buy'
Jun 4, 2014 10:10AM LeMaitre Vascular, Inc. Closes Public Offering of Common Shares
Jun 4, 2014 09:54AM Roth Comments on DoC Prelim. Countervailing Duties (SCTY) (SPWR) (FSLR) (YGE)
Jun 4, 2014 08:08AM Pharmacyclics (PCYC) KOL Event at ASCO Impresses Physicians; Roth Keeps at 'Buy'
Jun 3, 2014 09:42AM ORR in Sunesis Pharma's (SNSS) Vosaroxin + Decitabine Phase III Improves; Roth Affirms 'Buy' Rating
Jun 3, 2014 07:44AM Synta (SNTA) Management Ready to Take Company to Next Level; Roth Affirms 'Buy' Rating
Jun 3, 2014 07:29AM Roth Keeps Celldex (CLDX) at 'Focus Pick'; Strong Phase I Data for Varlilumab Only Adds to Story
Jun 2, 2014 11:55AM Cytokinetics (CYTK) BENEFIT-ALS Update 'Encouraging'; Roth Maintains 'Buy' Rating
Jun 2, 2014 11:16AM Roth Still Positive on Galena Biopharma (GALE) Following GALE-301 FBP Presentation; Issues Commentary
Jun 2, 2014 10:06AM Roth Keeps Pharmacyclics (PCYC) at Buy; Still Positive on Imbruvica Following Phase III RESONTAE
Jun 2, 2014 09:23AM UPDATE: Roth Capital Upgrades ImmunoCellular Therapeutics (IMUC) to Buy
Jun 2, 2014 08:19AM Roth Keeps TG Therapeutics (TGTX) as 'Focus Pick' Following ASCO Presentations
May 30, 2014 10:34AM Notable Analyst Rating Changes 05/30: (MFRM) (OVTI) (AVY) Upgraded; (SOL) (BLOX) (EXAS) Downgraded
May 30, 2014 09:25AM Roth Cuts ReneSola (SOL) to Neutral; DG Straegy, OEM Model are Both Negatives
May 30, 2014 08:10AM Roth Capital Downgrades ReneSola Ltd. (SOL) to Neutral
May 30, 2014 07:08AM Roth Positive on Retrophin's (RTRX) Thiola Licensing Deal; Issues Commentary
May 29, 2014 12:33PM Another Partnership in the Books, Focus Now on ASCO for Celldex (CLDX) - Roth
May 28, 2014 08:57AM Roth Affirms 'Buy' Rating on JinkoSolar (JKS); FY14 Project Outlook 'Encouraging'
May 23, 2014 09:41AM Superior Drilling Products (SDPI) IPO Opens Flat
May 23, 2014 09:09AM Superior Drilling Products (SDPI) IPO prices at $4, Below Expected Range
May 23, 2014 07:26AM Roth 'Encouraged' by Ligand/Viking Transaction; Maintains at 'Buy' (LGND)
May 23, 2014 06:52AM Roth Keeps Keryx Biopharma (KERX) at 'Buy' on PDUFA Update; Extension Preferred to CRL
May 22, 2014 03:23PM Trina Solar (TSL) On-Track to Reach Capacity Targets, but Poly Pricing Risk Remains
May 22, 2014 10:41AM Notable Analyst Rating Changes 05/22: (FB) (BAH) (NBR) Upgraded; (MT) (AEO) (SODA) Downgraded
May 22, 2014 09:28AM Pre-Open Stock Movers 5/22: (NTLS) (ROYL) (PLCE) (SN) Higher; (WUBA) (WB) (MOV) (SINA) Lower (more...)
May 22, 2014 07:57AM Roth Capital Adds TG Therapeutics (TGTX) to Focus List; Sees 2014 as 'Transformational'
May 22, 2014 06:39AM Roth Capital Starts Sarepta Therapeutic (SRPT) at Buy
May 22, 2014 06:38AM Roth Capital Downgrades Keurig Green Mountain (GMCR) to Neutral
May 19, 2014 06:42AM Roth Trims PT, Ests on Canadian Solar (CSIQ); Execution in Canada, Japan Now Key
May 16, 2014 01:49PM Hydrogenics Corp. (HYGS) Closes 1.5M Share Offering Priced at $15/sh
May 16, 2014 07:52AM Roth Capital Keeps Stemline (STML) at 'Buy'; Still Plenty to See and Do in 2014
May 16, 2014 06:56AM Roth Capital Starts Top Image Systems (TISA) at Buy
May 15, 2014 04:51PM Sphere 3D to Acquire Overland Storage (OVRL) in All-Stock Deal
May 15, 2014 08:40AM Roth Capital Starts Magellan Petroleum (MPET) at Buy
May 15, 2014 08:38AM Roth Slashes PT on Plug Power (PLUG) to $3.75; Amid Positive Outlook, Several Areas Still Need Addressing
May 15, 2014 08:14AM Roth Affirms Rexahn (RNN) at 'Buy'; Things Shaping Up for Solid Second-Half 2014
May 14, 2014 02:59PM Roth Boosts PT on Coronado (CNDO) to $1.70; Sidelined Until TSO, CNDO-109 Trajectory Clears Up
May 14, 2014 08:34AM Roth Capital Upgrades Summer Infant (SUMR) to Buy
May 13, 2014 09:20AM Roth Keeps Cytori Therapeutics (CYTX) at 'Buy'; Still Encouraged by Streamlining Efforts
May 13, 2014 06:59AM Roth Trims PT on Orion Energy Systems (OESX) to $6; LED Hiccup Doesn't Disrupt Story
May 12, 2014 06:38AM Roth Capital Upgrades Neogenomics (NEO) to Buy
May 9, 2014 10:47AM Roth Reiterates 'Sell' Rating, $1 PT on Dendreon (DNDN) Following Q1 Report; Totality of Risks Remain High
View More Recent Stories View Older Stories